TrialDiabetes care2012

Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants.

Josyf C Mychaleckyj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.